Acorda Therapeutics, Inc.
ACOR · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$253 | -$66 | -$104 | -$100 |
| Dep. & Amort. | $32 | $33 | $34 | $41 |
| Deferred Tax | -$43 | $31 | -$5 | $5 |
| Stock-Based Comp. | $0 | $1 | $3 | $8 |
| Change in WC | -$11 | $2 | $25 | -$12 |
| Other Non-Cash | $261 | -$22 | $6 | -$4 |
| Operating Cash Flow | -$14 | -$21 | -$41 | -$61 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$4 |
| Net Acquisitions | $0 | $0 | $74 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $64 |
| Other Inv. Act. | $0 | $0 | $74 | $64 |
| Investing Cash Flow | -$0 | -$0 | $74 | $59 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$70 | -$2 |
| Financing Cash Flow | $0 | $0 | -$70 | -$2 |
| Forex Effect | $0 | $1 | -$0 | $1 |
| Net Chg. in Cash | -$14 | -$21 | -$38 | -$2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44 | $65 | $103 | $105 |
| End Cash | $30 | $45 | $65 | $103 |
| Free Cash Flow | -$14 | -$21 | -$42 | -$65 |